293 related articles for article (PubMed ID: 34088413)
1. Fecal Microbiota Transplantation for Recurrent C difficile Infection During the COVID-19 Pandemic: Experience and Recommendations.
Khanna S; Tande A; Rubin DT; Khoruts A; Kahn SA; Pardi DS
Mayo Clin Proc; 2021 Jun; 96(6):1418-1425. PubMed ID: 34088413
[TBL] [Abstract][Full Text] [Related]
2. How to prepare stool banks for an appropriate response to the ongoing COVID-19 pandemic: Experiences in the Netherlands and a retrospective comparative cohort study for faecal microbiota transplantation.
Groenewegen B; van Lingen E; Ooijevaar RE; Wessels E; Feltkamp MCW; Boeije-Koppenol E; Verspaget HW; Kuijper EJ; van Prehn J; Keller JJ; Terveer EM;
PLoS One; 2022; 17(3):e0265426. PubMed ID: 35298520
[TBL] [Abstract][Full Text] [Related]
3. [Reconsidering the technical aspects and quality management background of faecal microbiota transplantation due to the novel coronavirus pandemic].
Nagy GG; Tudlik Z; Gergely L; Kónya J; Orosi P; Rákóczi É; Szabó J; Várvölgyi C; Vitális E; Paragh G
Orv Hetil; 2020 Nov; 161(44):1858-1871. PubMed ID: 33130602
[TBL] [Abstract][Full Text] [Related]
4. Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study.
Ianiro G; Bibbò S; Masucci L; Quaranta G; Porcari S; Settanni CR; Lopetuso LR; Fantoni M; Sanguinetti M; Gasbarrini A; Cammarota G
Dig Liver Dis; 2020 Dec; 52(12):1390-1395. PubMed ID: 33004295
[TBL] [Abstract][Full Text] [Related]
5. Fecal microbiota transplantation for treatment of patients with recurrent
Voth E; Khanna S
Expert Rev Anti Infect Ther; 2020 Jul; 18(7):669-676. PubMed ID: 32266848
[TBL] [Abstract][Full Text] [Related]
6. Gram-Negative Taxa and Antimicrobial Susceptibility after Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
Steed DB; Wang T; Raheja D; Waldman AD; Babiker A; Dhere T; Kraft CS; Woodworth MH
mSphere; 2020 Oct; 5(5):. PubMed ID: 33055258
[TBL] [Abstract][Full Text] [Related]
7. Updates and Challenges in Fecal Microbiota Transplantation for Clostridioides difficile Infection in Children.
Hourigan SK; Nicholson MR; Kahn SA; Kellermayer R
J Pediatr Gastroenterol Nutr; 2021 Oct; 73(4):430-432. PubMed ID: 34238831
[TBL] [Abstract][Full Text] [Related]
8. Superiority of Higher-Volume Fresh Feces Compared to Lower-Volume Frozen Feces in Fecal Microbiota Transplantation for Recurrent Clostridioides Difficile Colitis.
Agarwal A; Maheshwari A; Verma S; Arrup D; Phillips L; Vinayek R; Nair P; Hagan M; Dutta S
Dig Dis Sci; 2021 Jun; 66(6):2000-2004. PubMed ID: 32656604
[TBL] [Abstract][Full Text] [Related]
9. Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent
Mullish BH; McDonald JAK; Pechlivanis A; Allegretti JR; Kao D; Barker GF; Kapila D; Petrof EO; Joyce SA; Gahan CGM; Glegola-Madejska I; Williams HRT; Holmes E; Clarke TB; Thursz MR; Marchesi JR
Gut; 2019 Oct; 68(10):1791-1800. PubMed ID: 30816855
[TBL] [Abstract][Full Text] [Related]
10. Human Transmission of Blastocystis by Fecal Microbiota Transplantation Without Development of Gastrointestinal Symptoms in Recipients.
Terveer EM; van Gool T; Ooijevaar RE; Sanders IMJG; Boeije-Koppenol E; Keller JJ; Bart A; Kuijper EJ;
Clin Infect Dis; 2020 Dec; 71(10):2630-2636. PubMed ID: 31728525
[TBL] [Abstract][Full Text] [Related]
11. Fecal Microbiota Transplantation Influences Procarcinogenic Escherichia coli in Recipient Recurrent Clostridioides difficile Patients.
Nooij S; Ducarmon QR; Laros JFJ; Zwittink RD; Norman JM; Smits WK; Verspaget HW; Keller JJ; Terveer EM; Kuijper EJ;
Gastroenterology; 2021 Oct; 161(4):1218-1228.e5. PubMed ID: 34126062
[TBL] [Abstract][Full Text] [Related]
12. Fecal microbiota transplantation for recurrent Clostridioides difficile infection in frail and very old patients.
Montalto M; Gallo A; Agnitelli MC; Pellegrino S; Lipari A; Pero E; Covino M; Landi F; Gasbarrini A; Cammarota G; Ianiro G
J Am Geriatr Soc; 2023 Nov; 71(11):3530-3537. PubMed ID: 37458581
[TBL] [Abstract][Full Text] [Related]
13. Small Intestinal Bacterial Overgrowth: Should Screening Be Included in the Pre-fecal Microbiota Transplantation Evaluation?
Allegretti JR; Kassam Z; Chan WW
Dig Dis Sci; 2018 Jan; 63(1):193-197. PubMed ID: 29188472
[TBL] [Abstract][Full Text] [Related]
14. Implementation of fecal microbiota transplantation in a medical center for recurrent or refractory Clostridioides difficile infection and report of preliminary outcome.
Yeh YM; Cheng HT; Le PH; Chen CC; Kuo CJ; Chen CL; Chiu CT; Chiu CH
Biomed J; 2022 Jun; 45(3):504-511. PubMed ID: 34118466
[TBL] [Abstract][Full Text] [Related]
15. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure.
Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P
Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961
[TBL] [Abstract][Full Text] [Related]
16. Effect of Aging on the Composition of Fecal Microbiota in Donors for FMT and Its Impact on Clinical Outcomes.
Anand R; Song Y; Garg S; Girotra M; Sinha A; Sivaraman A; Phillips L; Dutta SK
Dig Dis Sci; 2017 Apr; 62(4):1002-1008. PubMed ID: 28181098
[TBL] [Abstract][Full Text] [Related]
17. Transmission and clearance of potential procarcinogenic bacteria during fecal microbiota transplantation for recurrent Clostridioides difficile.
Drewes JL; Corona A; Sanchez U; Fan Y; Hourigan SK; Weidner M; Sidhu SD; Simner PJ; Wang H; Timp W; Oliva-Hemker M; Sears CL
JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31578306
[TBL] [Abstract][Full Text] [Related]
18. Donor, patient age and exposure to antibiotics are associated with the outcome of faecal microbiota transplantation for recurrent Clostridioides difficile infection: A prospective cohort study.
Baunwall SMD; Hansen MM; Andreasen SE; Eriksen MK; Rågård N; Kelsen J; Grosen AK; Mikkelsen S; Erikstrup C; Dahlerup JF; Hvas CL
Aliment Pharmacol Ther; 2023 Sep; 58(5):503-515. PubMed ID: 37482926
[TBL] [Abstract][Full Text] [Related]
19. Effect of Oral Capsule- vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial.
Kao D; Roach B; Silva M; Beck P; Rioux K; Kaplan GG; Chang HJ; Coward S; Goodman KJ; Xu H; Madsen K; Mason A; Wong GK; Jovel J; Patterson J; Louie T
JAMA; 2017 Nov; 318(20):1985-1993. PubMed ID: 29183074
[TBL] [Abstract][Full Text] [Related]
20. Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.
Staley C; Kelly CR; Brandt LJ; Khoruts A; Sadowsky MJ
mBio; 2016 Dec; 7(6):. PubMed ID: 27999162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
